SEC Form 4 · accession 0001093557-17-000149
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jay S Skyler
Director
Period of report
Jun 1, 2017
Accepted (ET)
Jun 5, 2017 · 8:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2017 | A | 4,553 | $0.001 | A | 4,553 | D | |
| Common StockF2 | holding | — | — | — | 22,257 | I | by Partnership | |
| Common StockF3 | holding | — | — | — | 10,000 | I | by Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Share units are restricted and subject to vesting in one annual installment from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.
- F2Shares are held by Skyler Bach Family Limited Partnership, LLP, with respect to which the reporting person is a managing partner of the partnership and maintains voting rights of these shares.
- F3The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.